Riju Vashisht - 10 Jan 2026 Form 4 Insider Report for Genpact LTD (G)

Role
Senior Vice President
Signature
/s/ Thomas D. Scholtes, as Attorney-in-fact for Riju Vashisht
Issuer symbol
G
Transactions as of
10 Jan 2026
Net transactions value
-$1,264,906
Form type
4
Filing time
13 Jan 2026, 21:32:18 UTC
Previous filing
25 Aug 2025
Next filing
03 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Vashisht Riju Senior Vice President C/O GENPACT LLC, 521 FIFTH AVENUE, 14TH FLOOR, NEW YORK /s/ Thomas D. Scholtes, as Attorney-in-fact for Riju Vashisht 13 Jan 2026 0002014981

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction G Common Shares Tax liability $517,760 -10,733 -8.8% $48.24 111,537 10 Jan 2026 Direct F1
transaction G Common Shares Sale $747,146 -16,016 -14% $46.65 95,521 13 Jan 2026 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents shares withheld for payment of taxes upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan and exempt under Rule 16b-3.
F2 The sales transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2025.
F3 The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $46.40 to $47.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.